Which Rohto Eye Drops Are Recalled? 2026 Lot Checker

No—not every Rohto eye drop is recalled. The July 2026 action covers selected lots in eight Rohto Cooling Eye Drops package configurations, including 6,076,306 cartons of Max Strength 13 mL single packs. A bottle is affected only when its formulation, package format, lot code, and expiration match the applicable recall record.

The eight configurations are ALL-IN-ONE, Max Strength single pack, Max Strength Twin Pack, Optic Glow, Digi Eye, Dry Aid single pack, Dry Aid Twin Pack, and Cool Relief. That represents six formulation names because Max Strength and Dry Aid each have separate single- and twin-pack entries. Associated recall identifiers run from D-0715-2026 through D-0722-2026, according to national recall reporting.

The FDA-derived records describe a voluntary, firm-initiated, nationwide Class II recall initiated July 14, 2026. The stated reason is “lack of assurance of sterility.” The recalling firm is Rohto-Mentholatum (Vietnam) Co., Ltd. The openFDA enforcement results list the action as ongoing.

Select the package you bought, then enter the lot and expiration exactly as printed.

Why the Headlines Sound Brand-Wide

The received interpretation is understandable. Reports describing nearly 12 million bottles or more than 11 million cartons create the impression that the entire Rohto lineup is unsafe. A consumer seeing the brand name in that headline may reasonably decide to discard every Rohto bottle at home.

That approach is cautious, but it does not describe the recall’s actual boundaries. FDA enforcement records identify particular product configurations and bounded lot-and-expiration combinations. They do not announce an open-ended recall of every product carrying the Rohto name.

The scale is still substantial. Max Strength single packs account for 6,076,306 cartons, while Cool Relief accounts for 2,910,148 cartons. Three additional lines are reported at quantities ranging from 65,219 to 499,673 cartons each. Those figures explain the large national total without turning the action into a brand-wide recall.

The consensus is right about one point: a confirmed matching bottle should not be used. The narrower verdict concerns identification, not the response. Check the exact product and lot rather than assuming every Rohto product is included; stop using the drops if all recall identifiers match.

Eight Configurations, Not Five Products

A commonly shared openFDA query displays five records: Max Strength single pack, Cool Relief, Digi Eye, Dry Aid single pack, and Max Strength Twin Pack. Its metadata reports 13 database matches, but the query is explicitly limited to five results.

That five-record response is a partial search result, not proof that the recall contains only five retail products. Conversely, 13 enforcement-database matches do not necessarily represent 13 distinct products. Database records and consumer package configurations are not interchangeable.

Broader reporting identifies these eight configurations:

1. ALL-IN-ONE single pack
2. Max Strength 13 mL single pack
3. Max Strength Twin Pack with two 13 mL bottles
4. Optic Glow 13 mL single pack
5. Digi Eye 13 mL single pack
6. Dry Aid 10 mL single pack
7. Dry Aid Twin Pack
8. Cool Relief 13 mL single pack

The supplied evidence does not establish the Dry Aid Twin Pack’s size, UPC, NDC, or individual recall number. Those details should not be inferred from the single pack.

Package Format Changes Which Record Applies

A twin pack is not treated as two single packs for recall identification. Max Strength single and twin packs have different UPCs, NDCs, recall numbers, and affected-lot lists.

Max Strength single-pack NDC 10742-8158-1 differs from twin-pack NDC 10742-8158-2. A loose bottle removed from a two-bottle carton remains associated with the twin-pack record.

If the carton is missing, check a receipt, retailer account, online order history, or saved listing. Do not assume a loose bottle came from a single pack. If its original format cannot be established, the result is unresolved rather than safely outside the recall.

UPC and NDC values identify the record to consult; they do not replace the lot check. For example, UPC 310742010749 identifies Cool Relief 13 mL, but not every bottle carrying that UPC is recalled.

Only Max Strength Single-Pack Lots Are Fully Verified Here

The checker contains a complete directly documented list only for Rohto Cooling Eye Drops Max Strength, 13 mL single pack, UPC 310742011012, NDC 10742-8158-1, recall D-0716-2026. Its 27 distinct listed lots run from 3H2V and 3H3V expiring 2026/07 through lots expiring 2027/08.

Those lot-and-expiration pairs come from the individual openFDA record for D-0716-2026. The source repeats lot 4F2V in the 2027/05 group; the checker displays it once so the duplicate is not mistaken for another lot.

The supplied evidence does not provide equally complete, directly verified lists for the other seven configurations. Some third-party transcriptions contain ambiguous strings such as 4JIV, 512V, and 512VB. Those may be genuine codes or errors involving similar-looking letters and numbers.

For any configuration other than the Max Strength single pack, use the checker to identify the relevant package, then consult FDA recall event 99440 or the applicable individual enforcement record. An unavailable local verdict means the evidence here is incomplete; it does not mean the bottle is unaffected.

A Valid Check Uses Four Matching Details

First, read the complete formulation name. Use ALL-IN-ONE, Max Strength, Optic Glow, Digi Eye, Dry Aid, or Cool Relief—not bottle color, cap color, or the Rohto brand alone.

Second, determine whether it was sold as a single pack or twin pack. This is essential for Max Strength and Dry Aid.

Third, copy the lot and expiration exactly. Characters such as I and 1, O and 0, B and 8, or S and 5 can be difficult to distinguish. Use bright indirect light, magnification, or a focused photograph rather than guessing.

Fourth, match the formulation, package, lot, and expiration together. Treat the lot and expiration as a pair. Lot 3H2V, for example, is listed with expiration 2026/07 for the Max Strength single pack. The same code with a different expiration, on another formulation, or from a twin pack is not a match to D-0716-2026.

The evidence does not establish one universal location for lot and expiration markings across every Rohto carton and bottle. If the code is unreadable or identifiers conflict, contact the seller, manufacturer, or FDA rather than declaring the product affected or unaffected.

The openFDA response reports an underlying dataset update date of August 19, 2026. Because the records list the recall as ongoing, check the current record rather than relying solely on an old screenshot, search excerpt, social post, or copied lot list.

Class II Does Not Mean Every Bottle Was Contaminated

“Lack of assurance of sterility” means the required sterility assurance could not be established for the affected products. It does not prove that every recalled bottle was contaminated or that contamination was confirmed in a particular bottle.

The FDA classified the recalls as Class II. In FDA terminology, that means exposure may cause temporary or medically reversible adverse health effects, while the probability of serious adverse consequences is remote. The firm initiated the recall on July 14, 2026; the reported FDA classification date was July 23, 2026. Those are separate regulatory milestones.

The affected products were made in Vietnam and distributed in the United States by The Mentholatum Company of Orchard Park, New York.

Headline quantities do not determine an individual bottle’s status. Reports also use cartons, bottles, packages, and units inconsistently. Product identity, package configuration, lot number, and expiration provide the relevant test.

What to Do With a Matching Bottle

If all four identifiers match the current recall record, stop using the drops. Clear liquid, an intact seal, normal smell, or the absence of symptoms does not establish sterility.

Keep the bottle and carton while confirming current return, replacement, refund, or disposal instructions. Store the product separately so another household member does not use it accidentally.

Consumers have been directed to contact Mentholatum at 1-877-636-2677 about return or replacement options, according to eye-care trade coverage. The supplied evidence does not establish whether proof of purchase is required in every case, so verify the current terms before discarding the carton or traveling to a store.

For FDA recall information, call 1-888-INFO-FDA or 1-888-463-6332. Direct confirmation is particularly useful when the carton is missing, the code is unreadable, or the original package format cannot be determined.

Using recalled drops does not mean harm is certain. Stop using a confirmed match and contact a healthcare professional if symptoms appear, persist, or worsen. Warning signs identified in optometry-practice recall guidance include increasing redness, eye pain, light sensitivity, blurred vision, discharge, swelling, and sudden vision changes.

Sudden vision changes, eye pain, or light sensitivity warrant same-day clinical care. Severe or rapidly worsening symptoms require prompt evaluation rather than waiting for a refund decision or product-code confirmation. Bring the bottle and carton, if available, so the clinician can document the formulation, package, lot, and expiration.